Immunic (IMUX) Insider Trading & Ownership $0.99 +0.05 (+5.33%) As of 12:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunic (NASDAQ:IMUX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.60%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$128.55KNumber OfInsiders Selling(Last 12 Months)0 Get IMUX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunic stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMUX Insider Buying and Selling by Quarter Immunic Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/13/2025Duane NashChairmanBuy20,000$0.83$16,600.00 6/4/2025Daniel VittCEOBuy15,000$0.77$11,550.00 11/12/2024Richard Alan RudickDirectorBuy87,300$1.15$100,395.00 (Data available from 1/1/2013 forward) IMUX Insider Trading Activity - Frequently Asked Questions Who is on Immunic's Insider Roster? The list of insiders at Immunic includes Daniel Vitt, Duane Nash, Glenn Whaley, Joerg Neermann, and Richard Alan Rudick. Learn more on insiders at IMUX. What percentage of Immunic stock is owned by insiders? 4.60% of Immunic stock is owned by insiders. Learn more on IMUX's insider holdings. Which Immunic insiders have been buying company stock? The following insiders have purchased IMUX shares in the last 24 months: Daniel Vitt ($11,550.00), Duane Nash ($16,600.00), and Richard Alan Rudick ($100,395.00). How much insider buying is happening at Immunic? Insiders have purchased a total of 122,300 IMUX shares in the last 24 months for a total of $128,545.00 bought. Immunic Key ExecutivesDr. Duane D. Nash J.D. (Age 53)M.B.A., M.D., Executive Chairman Compensation: $504.57kDr. Daniel Vitt Ph.D. (Age 56)CEO, President & Director Compensation: $869.96kMr. Glenn Whaley CPA (Age 56)Chief Financial Officer Compensation: $576.85kDr. Andreas Muehler M.D. (Age 59)Ph.D., Chief Medical Officer Compensation: $694.86kDr. Hella Kohlhof (Age 50)Chief Scientific Officer Jessica BreuHead of Investor Relations & CommunicationsMr. Inderpal Singh (Age 57)General Counsel Mr. Patrick Walsh (Age 40)Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies Candel Therapeutics Insider Selling Tonix Pharmaceuticals Insider Selling Lifecore Biomedical Insider Selling Palvella Therapeutics Insider Selling Abeona Therapeutics Insider Selling Aldeyra Therapeutics Insider Selling Corvus Pharmaceuticals Insider Selling Annexon Insider Selling DBV Technologies Insider Selling Aerovate Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:IMUX) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMUX Stock Alerts